Sign In
Get Clay Free →

Suggestions

    Isaac Klein

    Chief Scientific Officer at Dewpoint Therapeutics

    Dr. Isaac Klein is a distinguished Physician-scientist, oncologist, and the Chief Scientific Officer at Dewpoint Therapeutics, a pioneering biotechnology company specializing in biomolecular condensates and drug discovery. Dewpoint's groundbreaking approach targets diseases like cancer, neurodegeneration, infectious diseases, and metabolic disorders by harnessing the potential of condensate biology.

    Drawing from an impressive educational background, Dr. Klein completed his Medical Oncology Fellowship, Internal Medicine Residency, and Doctor of Medicine (M.D.) studies at prestigious institutions such as Harvard Medical School and Joan & Sanford I. Weill Medical College of Cornell University. Moreover, his passion for research led him to earn a Doctor of Philosophy (Ph.D.) in Immunology, Genetics, and Molecular Biology from Rockefeller University, and a Bachelor’s Degree in Biological And Environmental Engineering from Cornell University.

    With a wealth of experience in the medical field, Dr. Klein has held notable positions including Medical Oncologist at Dana-Farber Cancer Institute, Instructor In Medicine at Harvard Medical School, Scientist at Whitehead Institute, and various roles at other esteemed institutions like Brigham and Women's Hospital, Rockefeller University, Sloan-Kettering, and Weill Cornell Medical College.

    Through his leadership at Dewpoint Therapeutics, Dr. Klein spearheads a diverse team of scientists across Boston, Dresden, and Berlin, dedicated to transforming condensate biology discoveries into groundbreaking treatments for challenging diseases. His commitment to advancing healthcare aligns with the inspirational words of pioneers like Edwin Hubble and Marshall Wolf, underscoring the profound impact of science and medicine on human well-being.

    Isaac Klein
    Add to my network

    Location

    Boston, Massachusetts, United States